Technology News

Press Releases
|
January 10, 2022

New study shows that the amount of active drug in cancer tablets may be reduced by 75% using the Dispersome® technology

January 10, 2022 (COPENHAGEN, Denmark). The Danish drug development company, Zerion Pharma A/S (ZERION) has completed a new animal study (in dogs) that clearly demonstrates the potential of its patented Dispersome®

Press Releases
|
February 9, 2021

Arla Foods Ingredients and ZERION announce agreement to secure supply of Lacprodan® BLG as key component in ZERION’s Dispersome® technology

(Copenhagen, February 9, 2021). Arla Foods Ingredients Group P/S (Arla), a subsidiary of Arla Foods amba, and drug formulation company Zerion ApS (ZERION) have entered into an agreement covering the supply of...